C12Y 603/02001
Pantoate-beta-alanine ligase
Official title: Pantoate-beta-alanine ligase (6.3.2.1)
C12Y603/02001 (Pantoate-beta-alanine ligase) appears on 4 US grants and 7 published applications in this corpus.
Search patents in C12Y- Granted patents
- 4
- Published applications
- 7
- Assignees
- 5
- Inventors
- 20
- Latest grant
- 24 Feb 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2004 | 0 | 2 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 0 |
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 1 |
| 2018 | 0 | 0 |
| 2019 | 1 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 0 |
| 2026 | 1 | 0 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Vectors and expression systems for producing recombinant proteins24 Feb 2026US 12,559,760 B2Amgen Inc.
- Vitamin prototrophy as a selectable marker17 Sep 2019US 10,415,043 B2Lanzatech New Zealand Limited
- Attenuated Mycobacterium tuberculosis vaccines25 May 2010US 7,722,861 B2
- Microorganisms and processes for enhanced production of pantothenate17 Jul 2007US 7,244,593 B2BASF SE
- Vectors and expression systems for producing recombinant proteins4 Aug 2022US 2022/0243222 A1Amgen Inc.
- Recombinant therapeutic interventions for cancer28 Jan 2021US 2021/0024940 A1The Johns Hopkins University
- Vitamin prototrophy as a selectable marker19 Jan 2017US 2017/0016007 A1Lanzatech New Zealand Limited
- Selection Method and Recombinant Microorganisms and uses Therefor28 Nov 2013US 2013/0316364 A1Lanzatech New Zealand Limited
- Microorganisms and processes for enhanced production of pantothenate10 Jul 2008US 2008/0166777 A1BASF SE
Most cited
By later US patents